These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21491581)

  • 1. Donation after cardiac death organs for patients with hepatitis C virus: are we rolling the dice, or are they just as good as any?
    Bunchorntavakul C; Reddy KR
    Liver Transpl; 2011 Jun; 17(6):625-7. PubMed ID: 21491581
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
    Taner CB; Bulatao IG; Keaveny AP; Willingham DL; Pungpapong S; Perry DK; Rosser BG; Harnois DM; Aranda-Michel J; Nguyen JH
    Liver Transpl; 2011 Jun; 17(6):641-9. PubMed ID: 21618684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
    Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
    Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hepatitis C virus recurrence is nearly universal after donation after cardiac death liver transplant.
    Ortiz J; Feyssa EL; Parsikia A; Azhar A; Hashemi N; Campos S; Khanmoradi K; Zaki R; Balasubramanian M; Araya V
    Exp Clin Transplant; 2011 Apr; 9(2):105-12. PubMed ID: 21453227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of hepatitis C cirrhosis after liver transplantation.
    Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
    Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
    Langrehr JM; Puhl G; Bahra M; Schmeding M; Spinelli A; Berg T; Schönemann C; Krenn V; Neuhaus P; Neumann UP
    Liver Transpl; 2006 Apr; 12(4):644-51. PubMed ID: 16555324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of hepatitis C-infected grafts in liver transplantation.
    Arenas JI; Vargas HE; Rakela J
    Liver Transpl; 2003 Nov; 9(11):S48-51. PubMed ID: 14586895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
    Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
    Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus-infected donors in liver transplantation.
    Peek R; Reddy KR
    Gastroenterology; 2007 Aug; 133(2):381-2. PubMed ID: 17681155
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term outcomes of donation after cardiac death liver allografts from a single center.
    Nguyen JH; Bonatti H; Dickson RC; Hewitt WR; Grewal HP; Willingham DL; Harnois DM; Schmitt TM; Machicao VI; Ghabril MS; Keaveny AP; Aranda-Michel J; Satyanarayana R; Rosser BG; Hinder RA; Steers JL; Hughes CB
    Clin Transplant; 2009; 23(2):168-73. PubMed ID: 19220366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression.
    Toniutto P; Minisini R; Fabris C; De Feo T; Marangoni F; Burlone M; Avellini C; Bitetto D; Fornasiere E; Fumolo E; Baccarani U; Pirisi M
    Clin Transplant; 2009; 23(2):184-90. PubMed ID: 19210526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of extended criteria donors in hepatitis C virus-positive recipients.
    Berenguer M
    Liver Transpl; 2008 Oct; 14 Suppl 2():S45-50. PubMed ID: 18825715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of anti-hepatitis C virus seropositive organs in liver transplantation.
    Mulligan DC; Goldstein RM; Crippin JS; Abouljoud MS; Levy MF; Husberg BS; Gonwa TA; Foster BR; Tillery GW; Klintmalm GB
    Transplant Proc; 1995 Feb; 27(1):1204-5. PubMed ID: 7878850
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience.
    Grewal HP; Willingham DL; Nguyen J; Hewitt WR; Taner BC; Cornell D; Rosser BG; Keaveny AP; Aranda-Michel J; Satyanarayana R; Harnois D; Dickson RC; Kramer DJ; Hughes CB
    Liver Transpl; 2009 Sep; 15(9):1028-35. PubMed ID: 19718636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Course of the recurrence of hepatitis C virus infection after liver transplantation].
    Gugenheim J; Baldini E; Ouzan D; Mazza D; Saint-Paul MC; Goubaux B; Mouiel J
    Gastroenterol Clin Biol; 1996; 20(10):730-5. PubMed ID: 8991141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches to treatment of recurrent hepatitis C virus following liver transplantation using ribavirin.
    Bizollon T; Adahm M; Ducerf C; Baulieux J; Trepo C
    Transplant Proc; 1996 Oct; 28(5):2842-3. PubMed ID: 8908092
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
    Maluf DG; Edwards EB; Stravitz RT; Kauffman HM
    Liver Transpl; 2009 Jun; 15(6):592-9. PubMed ID: 19479802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.